Observational study of neutropenic patients in Cologne
The Cologne Cohort of Neutropenic Patients (CoCoNut) - a Non-interventional Cohort Study Assessing Risk Factors, Interventions, and Outcome of Immunosuppressed Patients With or Without Opportunistic Infections
University Hospital of Cologne · NCT01821456
This study looks at patients who have low white blood cell counts after chemotherapy for blood cancers to see how it affects their health and what treatments work best for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100000 (estimated) |
| Ages | 1 Year and up |
| Sex | All |
| Sponsor | University Hospital of Cologne (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Cologne, North Rhine-Westphalia) |
| Trial ID | NCT01821456 on ClinicalTrials.gov |
What this trial studies
The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study that focuses on patients who develop neutropenia after chemotherapy for hematological malignancies. This prospective study aims to collect comprehensive data on risk factors, interventions, and outcomes for these immunosuppressed patients, including those with opportunistic infections. The research is conducted at the University Hospital of Cologne, where patients are monitored and assessed for their health status and treatment responses.
Who should consider this trial
Good fit: Ideal candidates for this study are immunosuppressed patients who have developed neutropenia following chemotherapy for cancer.
Not a fit: Patients who are not immunosuppressed or who have not undergone chemotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of neutropenia management and enhance treatment strategies for immunosuppressed patients.
How similar studies have performed: Other observational studies have shown success in understanding the outcomes of neutropenic patients, making this approach both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * immunosuppressed patients Exclusion Criteria: * none
Where this trial is running
Cologne, North Rhine-Westphalia
- University Hospital of Cologne — Cologne, North Rhine-Westphalia, Germany (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hematological Malignancies, Cancer, Chemotherapy, Neutropenia, Immunosuppression, hematological malignancies, cancer, chemotherapy